The Role of the Immune and Inflammatory Systems in Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-07

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To define the cytokine and cellular immune signature of primary hypertension. Cross sectional clinical/laboratory study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.

NCT01903642

Inflammatory Disease

TERMINATED NA

Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study

NCT04932954

Covid19

UNKNOWN

Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases

NCT02839278

Inflammation

COMPLETED NA

Promoting Immune Health by Intermittent Fasting: a Pilot Study

NCT05898360

Metabolic Syndrome HEALTHY VOLUNTEERS Time Restricted Feeding +2 more

UNKNOWN NA

Vasculopathy, Inflammation and Systemic Sclerosis

NCT02562079

Systemic Sclerosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Experimental data show the presence of immune and inflammatory systems dysregulation in hypertension. Understanding of the inflammatory and immune nature of hypertension is currently based on studies in rodent models of hypertension, but is supported by human epidemiological and genome wide association studies (GWAS) studies. It is now essential to identify key checkpoints and inflammatory mechanism(s) involved in human hypertension in comprehensive and sufficiently powered studies, which will then be able to guide subsequent in-depth hypothesis-driven mechanistic studies. This approach may provide the basis for future randomized clinical trials (RCTs).

To define the relationships and predictive value of the immune signature of hypertension and clinical phenotypes of hypertension :

* Predictive value of immune signature for blood pressure parameters measured by ambulatory blood pressure measurements (ABPM)
* Predictive value of immune signature for endothelial function assessed by Endo-PAT2000 and flow mediated dilatation (FMD) both complementary non-invasive techniques.
* Predictive value of immune signature for vascular stiffness and central pressure assessed by SphygmoCor
* Predictive value of immune signature for renal function parameters
* Predictive value of immune signature for cognitive function. To define genetic determinants of immune signature of hypertension.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Inflammation Vascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

80 with hypertension, defined on office BP readings and confirmed with ambulatory blood pressure monitoring.

Clinical and laboratory assessment. NO intervention.

None involved

Intervention Type OTHER

NO intervention

Control

80 WITHOUT hypertension, defined on office BP readings and confirmed with ambulatory blood pressure monitoring.

Clinical and laboratory assessment. NO intervention.

None involved

Intervention Type OTHER

NO intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

None involved

NO intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18-55 years
* Cases: Office blood pressure ≥140 and ≥90
* Controls: Office blood pressure \<140 and \<90 and age, sex and BMI matching to cases

Exclusion Criteria

* Age \>55 years old;
* Secondary hypertension (including e.g. adrenal tumours, pheochromocytoma, renal artery stenosis; thyroid disease)
* Acute inflammatory disorders incl. flu, rhinitis, sinusitis etc. within 3 weeks;
* hospitalization within the past 3 months;
* Life expectancy of \< 3 years;
* History of alcohol/substance abuse
* Inflammatory conditions e.g. Allergic disorders; chronic infections, COPD, tuberculosis; hepatitis B or C; pneumonitis, bronchiectasis; pericardial or pleural effusion, ascites; liver disease;
* Chronic inflammatory/autoimmune conditions such (e.g. SLE, rheumatoid arthritis, ulcerative colitis/Crohn's disease; non-basal cell malignancy or myelo- or lymphoproliferative disease within the past 5 years; known HIV+; Immunizations (3 months); pulmonary hypertension;
* Pregnancy, nursing;
* History of symptomatic coronary artery disease (events) or heart failure;
* BMI\>40,
* diabetes/glucose intolerance (fasting glucose, HbA1; testing, glucose challenge where indicated);
* Known albuminuria/microalbuminuria;
* GFR\<60mL/min/1.73m2.
* Any chronic concurrent treatment: Use of systemic or local steroids/immunosuppressive agents (within 6 months) of the inclusion; Current (within past 3 months) use of anti-hypertensive medication;
* Major depressive illness or other psychiatric conditions.
* Participants who decline participation in the study or who are unable to provide informed consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes